Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
51.72
Price to sales ratio
12.76

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
69
TMO
Thermo Fisher Scientific Inc Common Stock
528.54 USD+0.29%+1.15%+12.82%+23.69%196.42 B USD
106
DHR
Danaher Corporation Common Stock
200.18 USD+0.63%+1.16%+10.66%+0.64%141.68 B USD
379
NTRA
Natera, Inc. - Common Stock
272.89 USD+1.09%-4.07%+27.73%+72.49%39.08 B USD
388
A
Agilent Technologies, Inc. Common Stock
133.98 USD-0.26%+1.48%+2.36%+13.56%37.84 B USD

Frequently asked questions about IDEXX Laboratories, Inc. - Common Stock

What is the IDEXX Laboratories, Inc. - Common Stock stock price today?

The current price of IDEXX Laboratories, Inc. - Common Stock (IDXX) is 564.21. Over the past 24 hours, the stock has changed by +0.11%. Follow the IDXX chart for real-time price dynamics.

What is the stock ticker of IDEXX Laboratories, Inc. - Common Stock?

IDEXX Laboratories, Inc. - Common Stock trades under the ticker IDXX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is IDEXX Laboratories, Inc. - Common Stock stock going up?

IDXX has changed by -1.36% over the last week, -0.17% over the last month, and +6.11% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was IDEXX Laboratories, Inc. - Common Stock net income for the last quarter?

IDEXX Laboratories, Inc. - Common Stock reported net income of 278.45 M for the last quarter. The previous quarter showed 248.19 M, which means net income changed by +12.19%.

How many employees does IDEXX Laboratories, Inc. - Common Stock have?

As of the latest available data, IDEXX Laboratories, Inc. - Common Stock has 11 K employees. Workforce size can provide additional context about the company's scale and operations.

What is IDEXX Laboratories, Inc. - Common Stock EBITDA?

IDEXX Laboratories, Inc. - Common Stock EBITDA is 392.38 M, and its EBITDA margin is 34.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy IDEXX Laboratories, Inc. - Common Stock stock?

You can buy IDEXX Laboratories, Inc. - Common Stock (IDXX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in IDEXX Laboratories, Inc. - Common Stock stock?

Investing in IDEXX Laboratories, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IDXX chart and related analysis on metatrader.com as part of your research.

IDEXX Laboratories, Inc. - Common Stock

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.

News